Alessandro Maggi

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice

Massimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti et al. · Annals of Hematology · 2018 · 40 citations

Medicine, Hematology, Oncology +5

Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. GISSI--Avoidable Delay Study Group

M. G. Franzosi, Claudio Fresco, E. Geraci et al. · Archives of Internal Medicine · 1995 · 26 citations

Medicine, Cardiology, Internal Medicine +14

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network

Giorgina Specchia, Patrizia Pregno, Massimo Breccia et al. · Frontiers in Oncology · 2021 · 19 citations · Full text

Medicine, Hematology, Pharmacology +11

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study

Alessandra Iurlo, Daniele Cattaneo, Dario Consonni et al. · Frontiers in Pharmacology · 2023 · 19 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +12

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

Alessandra Iurlo, Daniele Cattaneo, Silvia Artuso et al. · Frontiers in Oncology · 2022 · 17 citations · Full text

Medicine, Hematology, Pharmacotherapy +11